Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial
2008 ◽
Vol 25
(7)
◽
pp. 818-825
◽
1993 ◽
Vol 87
(2)
◽
pp. S29
1981 ◽
Vol 38
(2)
◽
pp. 133
◽
1985 ◽
Vol 79
(5)
◽
pp. 13-17
◽
2012 ◽
Vol 29
(12)
◽
pp. 1529-1533
◽
1994 ◽
Vol 8
(1)
◽
pp. 27-32
◽